For the first time in nearly two decades, the FDA has approved a device intended to treat acute coronary artery perforations. The PK Papyrus covered coronary stent system, from Biotronik Inc., of Lake Oswego, Ore., won approval under a humanitarian device exemption for use in the emergency treatment of tears in the blood vessels of the heart.